Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone